» Articles » PMID: 32870495

Renal Dysfunction in Cardiovascular Diseases and Its Consequences

Overview
Journal J Nephrol
Publisher Springer
Specialty Nephrology
Date 2020 Sep 2
PMID 32870495
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

It is well known that the heart and kidney and their synergy is essential for hemodynamic homeostasis. Since the early XIX century it has been recognized that cardiovascular and renal diseases frequently coexist. In the nephrological field, while it is well accepted that renal diseases favor the occurrence of cardiovascular diseases, it is not always realized that cardiovascular diseases induce or aggravate renal dysfunctions, in this way further deteriorating cardiac function and creating a vicious circle. In the same clinical field, the role of venous congestion in the pathogenesis of renal dysfunction is at times overlooked. This review carefully quantifies the prevalence of chronic and acute kidney abnormalities in cardiovascular diseases, mainly heart failure, regardless of ejection fraction, and the consequences of renal abnormalities on both organs, making cardiovascular diseases a major risk factor for kidney diseases. In addition, with regard to pathophysiological aspects, we attempt to substantiate the major role of fluid overload and venous congestion, including renal venous hypertension, in the pathogenesis of acute and chronic renal dysfunction occurring in heart failure. Furthermore, we describe therapeutic principles to counteract the major pathophysiological abnormalities in heart failure complicated by renal dysfunction. Finally, we underline that the mild transient worsening of renal function after decongestive therapy is not usually associated with adverse prognosis. Accordingly, the coexistence of cardiovascular and renal diseases inevitably means mediating between preserving renal function and improving cardiac activity to reach a better outcome.

Citing Articles

Perirenal fat differs in patients with chronic kidney disease receiving different vitamin D-based treatments: a preliminary study.

Checa-Ros A, Locascio A, Okojie O, Abellan-Galiana P, DMarco L BMC Nephrol. 2025; 26(1):119.

PMID: 40045219 PMC: 11883930. DOI: 10.1186/s12882-025-04041-2.


Chronic Kidney Disease Following Cardiac Arrest Manifesting as Dyspnoea and Peripheral Oedema in Cardiovascular Multimorbidity: Case Analysis and Brief Literature Review.

Harding K, Emblin K, Ichim A, Adlington D, Daniels R, Mokbel K In Vivo. 2025; 39(2):1182-1189.

PMID: 40010965 PMC: 11884450. DOI: 10.21873/invivo.13922.


Machine learning-based interpretation of non-contrast feature tracking strain analysis and T1/T2 mapping for assessing myocardial viability.

GhaffariJolfayi A, Salmanipour A, Heshmat-Ghahdarijani K, MozafaryBazargany M, Azimi A, Pirouzi P Sci Rep. 2025; 15(1):753.

PMID: 39755814 PMC: 11700106. DOI: 10.1038/s41598-024-85029-0.


The Dual Burden: Exploring Cardiovascular Complications in Chronic Kidney Disease.

Caturano A, Galiero R, Rocco M, Tagliaferri G, Piacevole A, Nilo D Biomolecules. 2024; 14(11).

PMID: 39595570 PMC: 11591570. DOI: 10.3390/biom14111393.


Bioimpedance Analysis in CKD and HF Patients: A Critical Review of Benefits, Limitations, and Future Directions.

La Porta E, Faragli A, Herrmann A, Lo Muzio F, Estienne L, Nigra S J Clin Med. 2024; 13(21).

PMID: 39518641 PMC: 11546501. DOI: 10.3390/jcm13216502.


References
1.
Anand I, Bishu K, Rector T, Ishani A, Kuskowski M, Cohn J . Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure. Circulation. 2009; 120(16):1577-84. DOI: 10.1161/CIRCULATIONAHA.109.853648. View

2.
Bernaudo D, Coll R, Munoz-Torrero J, Pascual M, Garcia-Diaz A, Alvarez L . Renal function and short-term outcome in stable outpatients with coronary, cerebrovascular or peripheral artery disease. Atherosclerosis. 2013; 229(1):258-62. DOI: 10.1016/j.atherosclerosis.2013.04.029. View

3.
Ahmed A, Rich M, Sanders P, Perry G, Bakris G, Zile M . Chronic kidney disease associated mortality in diastolic versus systolic heart failure: a propensity matched study. Am J Cardiol. 2007; 99(3):393-8. PMC: 2708087. DOI: 10.1016/j.amjcard.2006.08.042. View

4.
Anand I . Cardiorenal syndrome: a cardiologist's perspective of pathophysiology. Clin J Am Soc Nephrol. 2013; 8(10):1800-7. PMC: 3789344. DOI: 10.2215/CJN.04090413. View

5.
Testani J, Khera A, St John Sutton M, Keane M, Wiegers S, Shannon R . Effect of right ventricular function and venous congestion on cardiorenal interactions during the treatment of decompensated heart failure. Am J Cardiol. 2010; 105(4):511-6. PMC: 2995805. DOI: 10.1016/j.amjcard.2009.10.020. View